Photo of Jennifer A. Moye,  PhD

Jennifer A. Moye, PhD

Harvard Medical School

Harvard Medical School
Phone: (774) 826-3721
Fax: (774) 826-3724

Jennifer A. Moye, PhD

Harvard Medical School


  • Associate Professor, Psychiatry, Harvard Medical School

Research Abstract

My research to date has focused on psychological adaptation to medical illness by older patients with a specific focus on the medical decision making process in patients with neurocognitive or neuropsychiatric illnesses. As a VA researcher, I have also been particularly interested in the role of trauma (i.e., combat trauma in military veterans) in psychological adaptation.

I am now extending this research to focus on cancer survivors in several areas:

1) To what extent to cancer patients report post traumatic stress symptomatology, and/or stress-related growth in response to cancer diagnosis and treatment;

2) How does earlier trauma experience relate to the onset and development of stress symptoms or stress related growth/ meaning making in cancer survivors (e.g., is earlier combat experience a protective or vulnerability factor);

3) How does cancer impact access and use of the healthcare system;

4) How do stress symptoms impact approach/avoidance to advance care planning.


Powered by Harvard Catalyst
  • Naik AD, Uy N, Anaya DA, Moye J. The effects of age, education, and treatment on physical, sexual and body concern symptoms among multimorbid, colorectal cancer survivors. 2015. PubMed
  • Karel MJ, Mulligan EA, Walder A, Martin LA, Moye J, Naik AD. Valued life abilities among veteran cancer survivors. Health Expect 2015. PubMed
  • Wachen JS, Patidar SM, Mulligan EA, Naik AD, Moye J. Cancer-related PTSD symptoms in a veteran sample: association with age, combat PTSD, and quality of life. 2014; 23:921-7. PubMed
  • Borkowsky W, Yogev R, Muresan P, McFarland E, Frenkel L, Fenton T, Capparelli E, Moye J, Harding P, Ellis N, Heckman B, Kraimer J. Structured treatment interruptions (STIs) in HIV-1 infected pediatric populations increases interferon gamma production and reduces viremia. Vaccine 2008; 26:3086-9. PubMed
  • Mirochnick M, Nielsen-Saines K, Pilotto JH, Pinto J, Jimenez E, Veloso VG, Parsons T, Watts DH, Moye J, Mofenson LM, Camarca M, Bryson Y. Nevirapine concentrations in newborns receiving an extended prophylactic regimen. J Acquir Immune Defic Syndr 2008; 47:334-7. PubMed
  • Borkowsky W, Yogev R, Muresan P, McFarland E, Frenkel L, Fenton T, Capparelli E, Moye J, Harding P, Ellis N, Heckman B, Kraimer J. Planned multiple exposures to autologous virus in HIV type 1-infected pediatric populations increases HIV-specific immunity and reduces HIV viremia. AIDS Res Hum Retroviruses 2008; 24:401-11. PubMed
  • Moye J, Butz SW, Marson DC, Wood E. A conceptual model and assessment template for capacity evaluation in adult guardianship. Gerontologist 2007; 47:591-603. PubMed
  • Moye J, Wood S, Edelstein B, Armesto JC, Bower EH, Harrison JA, Wood E. Clinical evidence in guardianship of older adults is inadequate: findings from a tri-state study. Gerontologist 2007; 47:604-12. PubMed
  • Pahwa S, Muresan P, Sleasman J, Fenton T, Moye J, Deveikis A, Wara D, Van Dyke R. Phase I/II trial of intermittent subcutaneous IL-2 administration in pediatric patients with moderate immune suppression: results of Pediatric AIDS Clinical Trials Study 402. J Allergy Clin Immunol 2007; 119:1538-41. PubMed
  • Karel MJ, Moye J, Bank A, Azar AR. Three methods of assessing values for advance care planning: comparing persons with and without dementia. J Aging Health 2007; 19:123-51. PubMed
  • Moye J, Marson DC. Assessment of decision-making capacity in older adults: an emerging area of practice and research. J Gerontol B Psychol Sci Soc Sci 2007; 62:P3-P11. PubMed
  • Moye J, Karel MJ, Gurrera RJ, Azar AR. Neuropsychological predictors of decision-making capacity over 9 months in mild-to-moderate dementia. J Gen Intern Med 2006; 21:78-83. PubMed